UZEDY® Surges to $117M in Sales in 2024, First Full Year of Commercialization
January 29, 2025
2025 Financial Calendar
January 15, 2025
Medincell to Join the Euronext SBF 120 Index
December 12, 2024
[Replay] Videoconference – H1 2024-25 Results
December 10, 2024
Consolidated Half-Year Financial Results
December 10, 2024
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM
December 9, 2024
Videoconference and publication of half-year financial results, Tuesday, December 10, 2024
November 29, 2024
25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI clinical Phase 3
November 6, 2024
New Phase 3 Positive Results for Olanzapine LAI and Real-World Data on UZEDY®
November 4, 2024
Participation in Leading Investor Conferences
October 28, 2024
